Group One Trading, L.P. 9 Meters Biopharma, Inc. Transaction History

Group One Trading, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$0.21 - $0.32 $3,368 - $5,132	-16,039 Reduced 7.74%	191,138 $41,000
Q2 2022 Aug 11, 2022	BUY	$0.26 - $0.64 $36,916 - $90,872	141,988 Added 217.81%	207,177 $54,000
Q1 2022 May 12, 2022	SELL	$0.52 - $1.0 $72,202 - $138,851	-138,851 Reduced 68.05%	65,189 $39,000
Q4 2021 Feb 11, 2022	SELL	$0.85 - $1.33 $230,640 - $360,884	-271,342 Reduced 57.08%	204,040 $200,000
Q3 2021 Nov 12, 2021	BUY	$1.03 - $1.41 $171,271 - $234,459	166,283 Added 53.8%	475,382 $618,000
Q2 2021 Aug 10, 2021	BUY	$1.04 - $1.5 $163,154 - $235,318	156,879 Added 103.06%	309,099 $340,000
Q1 2021 May 12, 2021	BUY	$0.84 - $2.16 $127,864 - $328,795	152,220 New	152,220 $178,000
Q4 2020 Feb 10, 2021	SELL	$0.65 - $1.11 $25,951 - $44,317	-39,926 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$0.48 - $0.84 $19,164 - $33,537	39,926 New	39,926 $33,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.